TOKYO: A major Japanese drugmaker said on Tuesday it was investigating one death from kidney dysfunction potentially linked to health supplements recalled last week by the firm.
It comes a day after the drugmaker, Kobayashi Pharmaceutical, said it was aware of 26 cases of people being hospitalized in relation to the prescription-free supplements.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.